Feeling 'better than well'

EMBO Reports

Volumn 5, Issue 12, 2004, Pages 1105-1109

  Hall, Wayne ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; CAFFEINE; CANNABIS; COCAINE; DIAMORPHINE; FLUOXETINE; LYSERGIDE; METHYLPHENIDATE; MORPHINE; NICOTINE; PLACEBO; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR;

ALCOHOLISM; ALZHEIMER DISEASE; AMNESIA; ATTENTION; BRAIN FUNCTION; COGNITION; DEPRESSION; DRUG DEPENDENCE; DRUG SAFETY; HEALTH CARE POLICY; HUMAN; HUMAN RIGHTS; MEDICAL ETHICS; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; MEMORY; MENTAL DISEASE; MENTAL PERFORMANCE; MOOD; MORALITY; NERVOUS SYSTEM FUNCTION; NEUROSCIENCE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW; RISK ASSESSMENT; SIDE EFFECT; TOBACCO DEPENDENCE; WELLBEING;

HEALTH CARE AND PUBLIC HEALTH; MENTAL HEALTH THERAPIES;

BRAIN; HUMANS; MENTAL HEALTH; PSYCHOLOGY; PSYCHOTROPIC DRUGS;

CANNABIS; NICOTIANA TABACUM;

EID: 12144266332     PISSN: 1469221X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.embor.7400303     Document Type: Review

References (34)

1. Andreasen NC (2001) Brave New Brain: Conquering Mental Illness in the Era of the Genome. Oxford University Press, New York, NY, USA
2. Babor TF et al (2003) Alcohol: No Ordinary Commodity; Research and Public Policy. Oxford University Press, Oxford, UK
3. Cami J, Farre M (2003) Drug addiction. N Engl J Med 349: 975-986
4. Caplan A (2002) No-brainer: can we cope with the ethical ramifications of new knowledge of the human brain? In Neuroethics: Mapping the Field, Marcus SJ (ed) pp 95-106. New York, NY, USA: The Dana Press
5. Caplan A (2003) Is better best? Sci Am 389: 84-85
6. Cohen RS (1998) The Love Drug: Marching to the Beat of Ecstasy. Haworth Medical Press, New York, NY, USA
7. Courtwright DT (1982) Dark Paradise: Opiate Addiction in America before 1940. Harvard University Press, Cambridge, MA, USA
8. Courtwright DT (2001) Forces of Habit: Drugs and the Making of the Modern World. Harvard University Press, Cambridge, MA, USA
9. Elliott C (2003) Better than Well: American Medicine meets the American Dream. WW Norton, New York, NY, USA
10. Farah MJ (2002) Emerging ethical issues in neuroscience. Nat Neurosci 5: 1123-1129
11. Farah MJ, Illes J, Cook-Deegan R, Gardner H, Kandel E, King P, Parens E, Sahakian B, Wolpe PR (2004) Neurocognitive enhancement: what can we do and what should we do? Nat Rev Neurosci 5: 421-425
12. Fukuyama F (2002) Our Posthuman Future: Consequences of the Biotechnology Revolution. Farrar, Straus & Giroux, New York, NY, USA
13. Goldstein A (1994) Addiction: From Biology to Drug Policy WH Freeman, New York, NY, USA
14. Goodman J (1994) Tobacco in History: The Cultures of Dependence. Routledge, London, UK
15. Haidt J (2001) The emotional dog and its rational tail: a social intuitionist approach to moral judgement. Psychol Rev 108 814-834
16. Hall SS (2003) The quest for a smart pill. Sci Am 289: 36-45
17. Hall WD (1999) Assessing the health and psychological effects of cannabis use. In The Health Effects of Cannabis, Kalant H, Corrigal W, Hall WD, Smart R (eds) pp 1-17. Toronto, Ontario, Canada: Addiction Research Foundation
18. Hall WD, Pacula R (2003) Cannabis Use and Dependence: Public Health and Public Policy. Oxford University Press, Oxford, UK
19. Healy D (2004) Let Them Eat Prozac: The Unhealthy Relationship Between the Pharmaceutical industry and Depression. New York University Press, New York, NY, USA
20. Hill EM, Newlin DB (2002) Evolutionary approaches to addiction: introduction. Addiction 97: 375-379
21. Kleiman M (1992) Against Excess: Towards a Drug Policy That Works. Basic Books, New York, NY, USA
22. Koob GF (2000) Neurobiology of addiction. Toward the development of new therapies. Ann NY Acad Sci 909: 170-185
23. Kramer P (1993) Listening to Prozac. Penguin, New York, NY, USA
24. Lachmann P (2001) Stem cell research - why is it regarded as a threat? EMBO Rep 2: 165-168
25. Melman MJ (2003) Wondergenes: Genetic Enhancement and the Future of Society. Indiana University Press, Bloomington, IN, USA
26. Musto D (1999) The American Disease: Origins of Narcotic Control. Oxford University Press, Oxford, UK
27. Parens E (ed) (1998) Enhancing Human Traits: Ethical and Social Implications. Georgetown University Press, Washington, DC, USA
28. Parens E (2002) How far will the treatment/enhancement distinction get us as we grapple with new ways to shape ourselves? In Neuroethics: Mapping the Field, Marcus SJ (ed) pp 152-158. New York, NY, USA: The Dana Press
29. President's Council on Bioethics (2003) Beyond Therapy: Biotechnology and the Pursuit of Happiness. Regan Books, New York, NY, USA
30. Stahl SM (2002) Essential Psychopharmacology of Antipsychotics and Mood Stabilizers. Cambridge University Press, New York, NY, USA
31. Stevens J (1987) Storming Heaven: LSD and the American Dream. William Heinemann, New York, NY, USA
32. Stock G (2002) Redesigning Humans: Choosing our Children's Genes. Profile Books, London, UK
33. World Health Organization (1998) Guidelines for Controlling and Monitoring the Tobacco Epidemic. WHO, Geneva, Switzerland
34. World Health Organization (2004) Neuroscience of Psychoactive Substance Use and Dependence. WHO, Geneva, Switzerland